["{\n\"step_by_step_thinking\": \"The question is about a 65-year-old man with metastatic lung cancer experiencing severe pain and dose-limiting side effects from oral morphine. The goal is to reduce his opioid need through interaction with the NMDA-receptor. This suggests that the recommended agent should be an analgesic that can help manage chronic pain, potentially reducing reliance on opioids. Among the options, ketamine is a medication that interacts with the NMDA-receptor and has been used for its analgesic properties.\",\n\"answer_choice\": \"B\"\n}"]